Background:
Peroxisome proliferator-activated receptor (PPAR)-beta/delta is a nuclear receptor transcription factor that regulates gene expression in many important biological processes. It is expressed ubiquitously, especially white adipose tissue, heart, muscle, intestine, placenta and macrophages but many of its functions are unknown. Saturated and polyunsaturated fatty acids activate PPAR-beta/delta, but physiological ligands have not yet been identified. In the present study, we investigated the anti-inflammatory effects of PPAR-beta/delta activation, through the use of GW0742 (0, 3 mg/kg 10 % Dimethyl sulfoxide (DMSO) i.p), a synthetic high affinity ligand, on the development of zymosan-induced multiple organ failure (MOF).
Methods:
Multiple organ failure (MOF) was induced in mice by administration of zymosan (given at 500 mg/kg, i.p. as a suspension in saline). The control groups were treated with vehicle (0.25 ml/mouse saline), while the pharmacological treatment was the administration of GW0742 (0, 3 mg/kg 10 % DMSO i.p. 1h and 6h after zymosan administration). MOF and systemic inflammation in mice was assessed 18 hours after administration of zymosan.
Results:
Treatment with GW0742 caused a significant reduction of the peritoneal exudate formation and of the neutrophil infiltration caused by zymosan resulting in a reduction in myeloperoxidase activity. The PPAR-beta/delta agonist, GW0742, at the dose of 0, 3 mg/kg in 10 % DMSO, also attenuated the multiple organ dysfunction syndrome caused by zymosan. In pancreas, lung and gut, immunohistochemical analysis of some end points of the inflammatory response, such as inducible nitric oxide synthase (iNOS), nitrotyrosine, poly (ADP-ribose) (PAR), TNF- and IL-1as well as FasL, Bax, Bcl-2 and apoptosis, revealed positive staining in sections of tissue obtained from zymosan-injected mice. On the contrary, these parameters were markedly reduced in samples obtained from mice treated with GW0742
Conclusions:
In this study, we have shown that GW0742 attenuates the degree of zymosan-induced non-septic shock in mice.

Further information:

Article source

Related posts:

1. Nitric oxide synthase modulates CFA-induced thermal hyperalgesia through cytokine regulation in mice
2. A CD36 synthetic peptide inhibits silica-induced lung fibrosis in the mice
3. Urokinase-type plasminogen activator and arthritis progression: role in systemic disease with immune complex involvement
4. Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis
5. Respiratory syncytial virus infection reduces lung inflammation and fibrosis in mice exposed to vanadium pentoxide